Interesting history and breakdown of Provenge..

Here is an article about Provenge that might be of interest to some..

http://www.cancernetwork.com/news/display/article/10165/1739217

As someone who has followed Provenge's progress for several years I think that is a very accurate and informative article. Thanks for sharing it with us.

There are just two minor points I'd like to make -- of the four members of the FDA panel who voted against the other thirteen as far as effectiveness goes, at least two had undisclosed financial interests in a competitor; and I believe the number of providers has been raised from the original fifty, since originally there was only one in New Jersey and as of several months ago three more were added, leading me to believe there were other additions throughout the country.